phosphorylation; regulatory proteins; contractility THROUGH EVOLUTIONARY PROCESSES the vertebrate heart has become increasingly complex. This is reflected in changes in anatomy as well as in the complexity of the mechanisms that regulate cardiac function. In early proto-vertebrates the heart was a simple muscular tube with pulsatile contraction (3) . Through the development of valves and septa, the heart became a multichambered organ in fishes with a single atrium and a single ventricle, where cardiac output is primarily regulated by changes in stroke volume (6, 15, 54) . Further morphological changes, as found in hearts of crocodilian and noncrocodilian reptiles, began to enable the separation of the pulmonary and systemic circulatory systems (33) . In endothermic species, such as humans and chickens, the heart has four contractile chambers with complete isolation of pulmonary and systemic circulation and heart rates that can exceed 600 beats per minute (6, 15, 60) . It is changes in heart rate, instead of stroke volume, that are the primary regulator of cardiac output in these endothermic animals (54) . Despite these changes in function and morphology, neither the basic mechanism responsible for triggering muscle contraction nor the complement of contractile proteins responsible for this phenomenon have changed. However, contractile protein isoforms do differ in primary amino acid sequence, which translates into functional differences in the sarcomere and give rise to differences in the physiological capability between hearts of different species (18) .
Evolutionary pressures have also driven the specialization of the different muscle types (fast skeletal, slow skeletal, and cardiac) within the same species. For example, one significant difference in the function of cardiac and fast skeletal muscle is in myocyte recruitment during contraction. Every time the heart beats each myocyte contracts while in fast skeletal muscle, myocytes are activated as needed to generate the required force (23) . As every myocyte contracts with each heart beat, additional control mechanisms have evolved within the vertebrate heart that allow for the graded activation of the contractile reaction. This enables significant modulation of the rate and strength of cardiac contraction, and as a result, cardiac output. In mammals, these control mechanisms include the FrankStarling response to sarcomere length, changes to the rate and magnitude of the Ca 2ϩ transient, as well as the modulation of specific regulatory proteins via phosphorylation (4, 23, 37) . While the Ca 2ϩ sensitivity of fast skeletal muscle is affected by sarcomere length, function is not regulated to the same degree is as cardiac muscle (2) .
Two proteins that are critical to the regulation of striated muscle function at the level of the sarcomere are troponin I (TnI), and myosin binding protein-C (MyBP-C). TnI is a component protein of the troponin (Tn) complex, the Ca 2ϩ activated trigger of the contractile reaction. MyBP-C is found in the A-bands of striated muscle sarcomeres where it binds myosin and/or actin to regulate cross-bridge cycling (51, 57, 61) . Comparison of the tissue-specific paralogs of these two regulatory proteins between different muscle types in humans reveals significant differences in their sequences as well as in the role that they play in regulating muscle function. For example, each of these proteins in the heart is a potential target for phosphorylation (42, 50, 55) . Such posttranslational modification results in changes in the Ca 2ϩ sensitivity and kinetics of force development and leads to changes in the rate and strength of cardiac contraction (31, 57, 62) . Protein kinase A (PKA), activated by ␤-adrenergic stimulation, targets two residues on human cardiac (c) TnI (46) and four residues on human cardiac (c) MyBP-C (30) . Protein kinase C (PKC), activated by ␣-adrenergic stimulation, can target five residues on human cTnI (42) as well as residues on cMyBP-C (38, 39, 69) . Interestingly, there is no evidence that the fast and slow skeletal isoforms of human TnI or MyBP-C are phosphorylated in vivo by either PKA or PKC (24, 58, 59, 65) . This suggests that there are differences in how cardiac muscle is regulated by the phosphorylation of TnI and MyBP-C compared with fast and slow skeletal muscle.
The goal of this study is to characterize how the primary amino acid sequences of TnI and MyBP-C have changed during the evolution of vertebrate striated muscle, and how tissue-specific paralogs have adapted to different physiological conditions. In particular, we investigated how the regulatory control mechanisms of striated muscle have developed during vertebrate evolution and the evolution of different muscle types. This work was accomplished by integrating phylogenetic analysis of all known amino acid sequences of TnI and MyBP-C with known functional characteristics of these two proteins. Included within this analysis are protein sequences from tunicates (urochordates), fishes, amphibians, reptiles, birds, the platypus, Ornithorhynchus anatinus, (monotreme), an opossum, Monodelphis domestica, (marsupial), and a large number of eutherian mammals. This collection of sequences from all vertebrate lineages enabled a comprehensive analysis of how TnI and MyBP-C have evolved within the different muscle types during vertebrate evolution. Through this synthesis we have gained new insight into how the regulation of striated muscle has evolved during the specialization of different muscle types. In addition, by examining the sequence alignments of each protein from such a broad array of species, we have identified patterns in the conservation of specific residues across the different orthologs and paralogs of each protein. These sequence motifs and specific residues represent potential targets for future studies into molecular interactions that regulate the function of these proteins.
METHODS
All sequences used in this study were obtained from either the National Center for Biotechnology Information (Bethesda, MD) nonredundant protein database (http://www.ncbi.nlm.nih.gov/guide/proteins/), the Ensembl Genome Browser (Wellcome Trust Genome Campus, Hinxton, Cambridge UK) (http://uswest.ensembl.org/index.html), or GenBank (http://www.ncbi.nlm.nih.gov/genbank/). For this study we obtained 147 TnI sequences from 52 different species and 139 sequences of MyBP-C from 44 different species. All efforts were made to get paralogs from fast skeletal muscle, slow skeletal muscle, and cardiac muscle for each species. This was not always possible as not all have been identified or annotated. For a number of the fish species there were multiple tissue-specific paralogs. A single isoform was chosen for such species by aligning the multiple sequences one at a time to the closest relative and noting the percent identity: the sequence with the highest percent identity was selected and used for further analysis. Also, a number of sequences contained missing data (Xs in sequence) and were therefore excluded from analysis. The final number of sequences used was 99 for TnI from 51 different species and 62 for MyBP-C from 26 different species. A complete list of all the TnI and MyBP-C sequences used in this study are shown in Tables 1 and 2 (see Supplementary Data for FASTA amino acid  sequences) . 1 Sequences were aligned and neighbor-joining trees (47) were generated using ClustalX2 (version 2.0.12) (36) . Further phylogenetic analyses were performed with the PHYLIP package (version 3.6b; Joe Felsenstein, Department of Genome Sciences, University of Washington, Seattle, WA) (16) . One hundred boot-strapped replicates of the data were created with Seqboot (PHYLIP). Maximum likelihood trees (using the PHYLIP program Proml) were created for all boot-strapped replicates with the Jones-Taylor-Thronton probability model, global rearrangements, and randomized order of sequence input (jumbled). Consensus trees were created with Consense (PHYLIP) using majority rule (extended) restrictions. All trees were rooted with midpoint rooting where the root is placed halfway between the two most distant taxa. Values at nodes represent the number of times (out of 100) that the specific branch point occurred. The program Figtree (version 1.2.2) (45) was used to examine and display all trees.
RESULTS

Phylogenetic analysis of TnI and MyBP-C.
The topology of the phylogenetic tree created for TnI reveals that there are separate clades for the sequences from each tissue type (Fig. 1) . In the TnI tree, cTnI is monophyletic with ssTnI, which both appear to have diverged from fast skeletal (fs) TnI, the ancestral form of TnI. The phylogenetic analysis of TnI demonstrates that there are three tissue-specific clades of TnI. The exception to this pattern is that cTnI from all fish species, including the zebrafish (Danio rerio), group with the ssTnI clade of the phylogenetic tree ( Fig. 1 ). This suggests that in fish there has been less divergence in the genes that encode for these two tissue-specific paralogs. Comparison of cTnI from all fish to that of other vertebrate species reveals that the NH 2 -terminal peptide found in most vertebrate cTnI is missing in cTnI from all fish species (see Fig. 3 ). It is this difference that likely makes fish cTnI isoforms more similar to slow skeletal (ss) TnI isoforms. Due to this similarity it is possible that some TnI isoforms that have been sequenced from the genomic DNA of fish species and identified as ssTnI may actually be expressed in the heart. Phylogenetic analysis of MyBP-C sequences resulted in monophyletic clades for each of the three tissue-specific isoforms (Fig. 2) . However, the MyBP-C tree suggests a different order for the separation of the tissue specific clades compared with the TnI tree ( Fig. 1) . Here, cMyBP-C paralogs are monophyletic, and the fast skeletal and slow skeletal paralogs cluster in a group that diverged from cMyBP-C, suggesting that cMyBP-C was the ancestral form of MyBP-C. One explanation for this difference, compared with the TnI tree, is that there were less MyBP-C sequences to be used in the tree building and these sequences did not cover the same range of vertebrate species. To test this we constructed new trees using only TnI and MyBP-C sequences that were found in the same species and tissues. While this reduced the number of sequences used in the analysis, the same result was found (data not shown).
Within each of the tissue-specific clades for both proteins, there is delineation between the sequence clusters for the different vertebrate groups. For example, within the mammals there is clear separation between cTnI and cMyBP-C from the platypus (monotreme), the opossum (marsupial), and eutherian mammals ( Figs. 1 and 2 ). In addition, mammals are clearly separated from birds and other vertebrate groups ( Figs. 1 and  2) . The pattern by which the cTnI and cMyBP-C isoforms from each vertebrate group diverge map well onto the accepted vertebrate phylogeny (see Fig. 5 ) (29) . These results illustrate that the sequence of the tissue-specific paralogs are well conserved in species of the same vertebrate group and that the changes that have occurred in parallel with the evolution and divergence of the different vertebrate groups. Sequence alignment analysis. Alignment of all sequences for TnI and MyBP-C reveal that there is a high degree of conservation across all sequences for each protein (Figs. 3 and 4). For example, two important sequence motifs in TnI are the inhibitory peptide (human residues 137-146) and switch peptide (147-162). When the muscle is relaxed the inhibitory peptide is bound to actin. This interaction prevents the movement of tropomyosin across the thin filament and the exposure of myosin binding sites. Following the Ca 2ϩ activation of TnC, TnI changes position and the switch peptide binds to the exposed hydrophobic patch on the NH 2 terminus of TnC. This change in the position of TnI, away from actin, releases tropomyosin and enables the exposure of myosin binding sites (31) . Comparison of the amino acid sequences of the inhibitory peptide and switch peptide across all known TnI isoforms demonstrates extremely high conservation (Fig. 3) . For example, the inhibitory peptide consists of ten residues and only one of these significantly varies between all TnI paralogs. A similar degree of conservation is found between the switch peptides across all TnI paralogs. The switch peptide is 16 residues in length of which 12 are identical across all known TnI isoforms. The remaining four have extremely low variation between the sequences (Fig. 3) . This conservation is remarkable considering that there is ϳ500 million years (My) of evolution separating humans and tunicates (70) and reflects the functional importance of these peptides to muscle function.
Similar levels of conservation are found when comparing MyBP-C sequences. The unique ϳ100 amino acid MyBP-C motif, or M-domain, is found in the NH 2 terminus of the protein between domains C1 and C2 (Fig. 4) and is essential for the regulation of actomyosin interactions. The M-domain binds myosin S2 (the hinge region of myosin connecting the S1 heads to the myosin rod) (24) as well as actin (52) to potentially limit cross-bridge formation. When phosphorylated by PKA, the M-domain no longer binds S2 (24) or actin (52), allowing cross bridges to form more readily and resulting in increases in cross-bridge cycling rates (32, 57) . Even though specific amino acids in the M-domain have not been implicated in functional effects, there are multiple regions in the Mdomain that are highly conserved (including residues 293-300 and 331-353, human numbering) that may be of functional importance. There are also regions of MyBP-C that are not well conserved and are completely unique to the cardiac paralog. All cMyBP-C isoforms contain an additional ϳ100 amino acid domain at the extreme NH 2 terminus (the C0 domain) which is not found in fsMyBP-C nor ssMyBP-C ( Supplementary Fig. S1 ). In addition, all cMyBP-C isoforms contain an insert in the M-domain that contains a PKA phosphorylation site (residues 276 to 284, human numbering) and a 28 amino acid insert in the C5-domain (residues 687 to 714, human numbering). The insertion in the M-domain, while present in all sequences studied, is more conserved within mammalian species than lower vertebrates. A sequence rich in Pro and Ala residues (the Pro-Ala rich region) is found between the C0 and C1 domains in cMyBP-C and at the extreme NH 2 terminus of fsMyBP-C and ssMyBP-C ( Supplementary  Fig. S1 ) that has previously been shown to scale with heart rate in mammals (51, 53). Several amino acids were identified in MyBP-C that are conserved depending on species. There are eight residues that switch from nonpolar and neutral charge in mammalian cMyBP-C to charged amino acids in all other isoforms (Fig. 4 and Supplementary Fig. S1 ). For example, in human cMyBP-C, and all other mammalian cardiac isoforms, there is a Gly at residue number 354 (or its equivalent), while there is an Arg at the equivalent site in nonmammalian cardiac iso- forms as well as all fast skeletal and slow skeletal isoforms. This substitution pattern is similar to the evolutionary loss of the His button in TnI (described below). The functional importance of these amino acids is unknown.
Evolution of regulatory control via phosphorylation of TnI and MyBP-C.
Phosphorylation of human cTnI and cMyBP-C by PKA and PKC represent important pathways for regulating cardiac output. The target residues enable the functional properties of the regulatory proteins to be directly modified. The results of the current study demonstrate that the number of phosphorylation targets in both cTnI and cMyBP-C increased during vertebrate evolution (Fig. 5) . As a result, the regulation of cardiac function became increasing complex. In human cTnI, Ser 23 and Ser 24 are located in the cardiac specific NH 2 -terminal peptide that is present in most cTnI isoforms. They are not present in any fsTnI or ssTnI isoforms. These two residues are targets for PKA and PKC (42) . As shown in Fig. 3 , this peptide is found in cTnI from all endothermic species, including eutherian mammals, marsupials, birds, as well as in the ectothermic amphibians and reptiles. It is not present, however, in cTnI from any fish species. There is an NH 2 -terminal extension in TnI from the tunicates but the sequence of this displays no similarity to that found in other vertebrate TnI isoforms. It is not known if the NH 2 -terminal peptide is present within monotremes, as only the COOH terminus of the cTnI gene in the platypus has been sequenced (residues 154 -210). As the NH 2 -terminal peptide is not present in either fsTnI or ssTnI, this suggests that it appeared in cTnI after the evolution of distinct muscle types. In addition to Ser 23 and Ser 24 , there are three additional targets for PKC on human cTnI: Ser 43 , Ser 45 , and Thr
144
. The current analysis demonstrates that all known cTnI isoforms contain a Ser residue at positions equivalent to 43 and 45 in human cTnI. Phosphorylation of these residues in human and rat cTnI decreases maximum tension and Ca 2ϩ sensitivity of force generation, lowers affinity of myosin S1 for actin, and reduces thin filament sliding speed (7, 41) . While there are potentially phosphorylatable residues (Ser or Thr) at positions equivalent to 43 and 45 in all ssTnI isoforms (Fig. 3) there is no evidence that they are phosphorylated in vivo (65) . fsTnI from all fish and amphibian species contain putative PKC targets at positions equivalent to Ser 43 , Ser 45 in human cTnI (Fig. 3) . These residues are however absent from the fsTnI of all mammal, bird, and reptile species (Fig. 3) . This suggests that these putative PKC targets were present in the ancestral form of TnI that through duplication generated the cTnI isoform. There have been no studies to date, however, to determine if they are phosphorylated in vivo. While these residues have been retained in cTnI and ssTnI in all species they were lost in fsTnI in a common ancestor to reptiles, birds, and mammals. As mentioned earlier, residue 144 in human cTnI is also a target for PKC. The current analysis demonstrates that there is a phosphorylatable residue present at this position (or at its equivalent) in cTnI from all known eutherian mammals as well as from two fish species (zebra fish, trout) and one amphibian species (cane toad) (Fig. 3) . However, no marsupial, bird, or reptile cTnI contains a phosphorylatable residue at this position nor is there a phosphorylatable residue at the equivalent position in ssTnI or fsTnI isoforms.
Four is found only in eutherian mammals (except pig and cow). In summary, cMyBP-C isoforms of vertebrate groups contain the following numbers of PKA phosphorylation sites: fish, 2; amphibians, 3; reptiles, 1; birds, 3; and mammals, 4. cMyBP-C sequence data for only one reptile (the anole lizard) were available, so conclusions regarding the number of PKA phosphorylation sites in reptilian cMyBP-C are not complete.
Residue changes within the COOH terminus of mammalian TnI. Examination of all TnI sequences reveals that every fsTnI and ssTnI isoform as well as TnI from the tunicate Ciona intestinalis contains a His, Val, and Asn at the positions equivalent to 132, 134, and 141 of human ssTnI. This pattern can be seen in Fig. 3 . These positions correspond to 163, 165, and 172 in human cTnI where there is an Ala, Glu, and His. These three residues are at the same relative positions in cTnI from all known eutherian mammals and the opossum, a marsupial (Fig. 3) . Work by Day et al. (13) suggests that the presence of His at position 132 in mammalian ssTnI helps to protect contractile function during cellular acidosis and have called this residue the "histidine button." Other studies have also suggested that the presence of Ala 163 in human cTnI is responsible, at least in part, for the loss of Ca 2ϩ sensitivity that occurs when the pH of the heart is decreased (63, 64, 66, 68) . In addition, transgenic mouse hearts expressing A164H cTnI (mouse cTnI equivalent) have improved function when challenged by hypoxia, acidosis, ischemia, and chronic heart failure compared with wild-type hearts (13) . Subsequent work by Westfall and Metzger (66) has demonstrated that Val 134 and Asn 141 in human ssTnI also reduce the impact of acidosis on contractile function.
Interestingly, as in human ssTnI, cTnI from all nonmammalian vertebrate species (amphibians, fishes, birds, etc.) contain a His at the equivalent position to 163 in human cTnI while the platypus (monotreme) has a Pro at this position (Fig. 3) . Also as in human ssTnI there is a Val and an Asn at the positions equivalent to 165 and 172 in cTnI from most animals (Fig. 3) . As mentioned above, the exceptions are the eutherian mammals and opossum as well as the platypus (Fig. 3) . In addition, all bird cTnI isoforms contain a Gly at the position equivalent to Asn 172 , while in cTnI from two amphibian species (Bufo marinus and Rana catesbeina) there is an Ala at the position equivalent to Val 172 . There is also a Glu at the position equivalent to Val 165 in Atlantic salmon. Together, these results suggest that the presence of His 131 , Val 134 , and Asn 141 in ssTnI (and at the equivalent positions in fsTnI) is the ancestral state and that Ala, Glu, and His at the equivalent positions in mammalian cTnI is the derived state.
DISCUSSION
In this study, we have investigated the roles of TnI and MyBP-C in the evolution of regulatory function in vertebrate striated muscle. The major results are that TnI and MyBP-C isoforms form distinct clades according to muscle types (car- diac, fast skeletal, and slow skeletal) and that the evolution of tissue-specific isoforms mimics the evolution of vertebrates. Regulatory features (e.g., phosphorylation sites) of TnI and MyBP-C evolved as vertebrates became more complex, with the most number of regulatory features found in eutherian mammalian species. We now further understand how the functions of TnI and MyBP-C have changed with respect to vertebrate evolution and can begin to investigate the functional contributions of conserved amino acid residues in each protein.
Evolution of TnI and MyBP-C isoforms. The current study suggests that a fast skeletal-like ortholog (fsTnI) is the ancestral form of TnI and that the gene for fsTnI would then have been duplicated, producing an isoform that evolved into the cardiac paralog. Subsequently, a second genome duplication occurred and one of the replicated cTnI genes evolved into the slow skeletal paralog. This finding supports previous work by Oota and Saitou (43) , who suggested, using thick and thin filament proteins, that the three muscle types found in vertebrates are the result of genome duplication events. Work by Chong and Jin (10), however, suggests that cTnI is the product of the duplication of the ssTnI gene that arose from the duplication of the fsTnI gene. These authors also suggest that there are evolutionary relationships between TnI and TnT with the two proteins arising from a TnI-like ancestor protein. This previous study used monoclonal antibodies to characterize similarities in protein conformation between different isoforms and fragments of recombinantly produced cTnI and cTnT. The difference in results between the Chong and Jin (10) study and the current results in regards to the order of TnI isoform evolution is likely due to different methodological approaches (antibody recognition of tertiary structure vs. sequence analysis).
Recent studies using multiple gene families have established that a number of genome duplication events occurred after the divergence of the urochordates [500 million years ago (Mya)] but before the divergence of the fish lineage (440 Mya) from the vertebrate lineage (28, 34) . Examination of the distribution of the TnI tissue paralogs present in the tunicates and the fish used in the present study suggests that the production of the three tissue-specific paralogs of TnI coincides with this time frame. Work by Cleto et al. (12) has identified a single gene for TnI in C. intestinalis that is expressed in the heart, the body wall, and the embryonic larval tail. The muscle in the body wall is homologous to vertebrate smooth muscle, while that in the heart and juvenile tail is homologous to vertebrate striated muscle (12, 40) . This indicates that any gene duplication events that produced multiple isoforms of TnI in the vertebrates occurred after the urochordate lineage diverged from the vertebrate lineage. Multiple TnI isoforms have been found in a second tunicate (Halocynthia roretzi), but phylogenetic analysis indicates that these evolved after the tunicate lineage derived from the vertebrate lineage (72) . Genome sequencing of the Atlantic salmon, Salmo salar, has identified separate genes for fsTnI, cTnI, and ssTnI. This indicates that the two genome duplication events responsible for the three tissuespecific paralogs occurred in a common ancestor of the bony fishes and all subsequent lineages. A number of species within the fishes have multiple isoforms of each of the tissue-specific paralogs. A similar finding has been reported for a variety of other cellular proteins and is the result of genome duplication events specific to the fish lineage that occurred after it diverged from the vertebrate lineage (1, 21, 22, 35, 48) .
According to the results of this study, cardiac MyBP-C is the ancestral form of MyBP-C, while slow skeletal and fast skeletal isoforms diverged afterwards (Fig. 2) . This pattern is different than that observed for TnI (Fig. 1) as well as other thick filament proteins (43) . One possible explanation for the difference between the MyBP-C phylogenetic tree topology and that of TnI and other muscle proteins is that the sequence of the cMyBP-C orthologs is very unlike that of fsMyBP-C or ssMyBP-C and that the fsMyBP-C and ssMyBP-C orthologs are highly similar to each other. As a result, fsMyBP-C and ssMyBP-C are monophyletic. In addition, the most parsimonious evolutionary path has cMyBP-C as the ancestor protein and the fast skeletal and slow skeletal clades derived from this ancestor. However, the changes in the sequence of cMyBP-C could have easily occurred after a gene duplication event that produced the slow skeletal paralog from the cardiac paralog. The sequence differences in cMyBP-C are reflective of it becoming highly specialized, understood to have arisen as cardiac muscle function specialized from fast skeletal and slow skeletal muscle function.
Evolution of functional roles of TnI and MyBP-C.
The influence of adrenergic stimulation on cardiac contractility is an important, and well characterized, regulatory mechanism of cardiac output (7, 9, 23, 31, 37, 55, 57, 71) . At the level of the sarcomere, force generation and cross-bridge cycling is modulated via the phosphorylation of TnI and MyBP-C following ␣-or ␤-adrenergic stimulation. Multiple phosphorylation sites exist in each protein: in human cTnI there are five known target residues for phosphorylation and in cMyBP-C there are four. Each of these is specifically targeted by PKA and/or PKC. The phosphorylation of the NH 2 -terminal peptide of human cTnI at Ser 23 and Ser 24 is thought to weaken the interaction between its NH 2 -terminal domain and the NH 2 -terminal domain of cTnC (9), thus decreasing the Ca 2ϩ affinity of cTnC site II and resulting in a loss of Ca 2ϩ sensitivity of myofilament activation (46) and an increase in the rate of relaxation (71) . PKA phosphorylation of cMyBP-C increases cross-bridge cycling rates (31, 57, 61, 62) possibly through abolishment of interactions between the NH 2 -terminal M-domain and actin (52) and/or myosin S2 (24) . While the function of fast and slow skeletal muscle in mammals is modified following adrenergic stimulation the effect is thought to be via changes in the kinetics of Ca 2ϩ cycling not in the contractile proteins (8) . The results of this study suggest that the TnI NH 2 -terminal peptide, containing two phosphorylatable targets, appeared in the vertebrate lineage after the fishes diverged but before the amphibians diverged (360 Mya). This represents a gain of regulatory control and correlates with the colonization of land by vertebrates. As the energetic cost of locomotion is higher in terrestrial animals compared with aquatic animals (49) , having the ability to match heart rate to aerobic requirement would increase the energy efficiency of the animal.
cTnI isoforms from nonmammalian species contain potential phosphorylation sites at Ser 43 , Ser 45 , and Thr 144 (or equivalents). The computer program NetPhos (5) gives a high score (Ͼ97%) for each of these putative phosphorylatable residues: however, no studies have examined if these residues are phosphorylated under physiological conditions. There are two explanations for the presence/absence of a phosphorylatable residue at position 144 in cTnI from different species: it appeared independently in the different groups (eutherians, fish, and amphibians), or a phosphorylatable residue was present at this location in cTnI in a common vertebrate ancestor that was then lost in all groups/species other than those mentioned. The second explanation is the most parsimonious given that a phosphorylatable residue is not found at a position equivalent to 144 in any fsTnI, suggesting that this addition occurred after the evolution of the cTnI paralog.
The complexity of PKA phosphorylation of cMyBP-C has increased through evolutionary time, with endothermic vertebrates (mammals, birds) containing more PKA phosphorylation sites in the M-domain of cMyBP-C isoforms than ectothermic vertebrates (reptiles, amphibians, fish). Ser 275 (human numbering) and Ser 304 are present in all vertebrates, whereas Ser 284 is only found in mammals, birds, and amphibians, and Ser 311 is only present in eutherian mammals (Fig. 4) . The fact that Ser 284 (or its equivalent) is not found in cMyBP-C isoforms of reptiles and fish is interesting because this site has been hypothesized to be a "gateway" site towards a hierarchical phosphorylation of cMyBP-C. Gautel with an Ala, Glu and His, respectively, in cTnI from all eutherian mammals and marsupials represents a change that has been maintained for over 148 million years (My). This suggests that these mutations in cTnI benefit cardiac function. Westfall and Metzger (66) have shown that the insertion of any of these residues (Ala, Glu and His) at their respective positions into ssTnI reduces the Ca 2ϩ sensitivity of myocyte contraction at physiological pH. We therefore hypothesize that it is this reduction in Ca 2ϩ sensitivity caused by these replacements in mammalian and marsupial cTnI that is the benefit. This is relevant because previous studies have shown that the Ca 2ϩ sensitivity of cardiac tissue isolated from trout, frog, rat and guinea pig increases to a similar degree as temperature is increased (11, 27) . In addition, when compared at 7°C, the Ca 2ϩ sensitivity of the trout heart and frog heart is ten-fold and eight-fold higher than that of the rat heart, respectively (11) . 7°C is a physiological temperature of the trout, and the Ca 2ϩ sensitivity of its heart at this temperature is similar to that of a rat heart at 37°C (20) . This means that if the temperature of the trout heart were increased to 37°C, its Ca 2ϩ sensitivity would increase and it would likely become locked in contracture. This would be due to Ca 2ϩ remaining bound to TnC. To avoid this condition, it was therefore necessary for the Ca 2ϩ sensitivity of the vertebrate heart to decrease as endothermy evolved and the physiological temperature of vertebrates increased. This is the reason why the Ca 2ϩ sensitivity of the mammalian heart is ten-fold less than that of the trout when compared at the same temperature. One mechanism responsible for lower Ca 2ϩ sensitivity is that the Ca 2ϩ affinity of mammalian cTnC is twofold lower that of trout cTnC (19) .
We now propose that a second mechanism by which the Ca 2ϩ sensitivity of the mammalian heart was reduced was via the mutation of mammalian cTnI to contain Ala 163 , Glu
165
, and His 172 . This change in sequence correlates with the appearance of endothermy in mammalian evolution. As mentioned above, cTnI isoforms from a variety of bird species contain a His and a Gly at positions equivalent to 163 and 165. This suggests that the replacement of His 163 with an Ala in eutherian cTnI occurred after the lineage that led to the birds diverged from the synapsid lineage that leads to eutherian mammals. However, the Ca 2ϩ sensitivity of force generation by cardiac tissue from the turkey and rat are similar when measured at the same temperature (25, 44) . This suggests that other mechanisms evolved to decrease the Ca 2ϩ sensitivity of the bird heart to enable function at high temperatures. In addition, as the Ca 2ϩ sensitivity of fast skeletal muscle is not as sensitive to temperature as cardiac muscle is (26), it was not necessary for its Ca 2ϩ sensitivity to be altered as endothermy evolved. Finally, the protective effect of inserting a His at residue 163 of cTnI may only be functional in mammalian hearts as Churcott et al. (11) have shown that Ca 2ϩ sensitivity of actin-activated myosin ATPase isolated from the trout heart is significantly affected by a 0.2 pH unit increase at 7.0. However, as these authors measured unloaded ATPase activity in solution, this result may not represent what would occur under more physiological conditions when contraction occurs against a load.
As a change in temperature alters the function of cellular proteins (56) , it is also likely that there have been changes during the evolution of endothermy to the functional characteristics of the membrane channels and transporters that regulate intercellular Ca 2ϩ . This includes the sarco/endoplasmic reticulum Ca 2ϩ ATPase, the ryanodine receptor, and L-type Ca 2ϩ channels. Work by Elias et al. (14) has shown that the activity of Na 2ϩ /Ca 2ϩ exchanger (NCX) cloned from the trout heart is temperature insensitive and, as a result, able to function at temperatures lower than canine NCX. Further work is needed to characterize how the other Ca 2ϩ handling proteins have changed during the evolution of the vertebrate heart.
While the presence of Ala
163
, Glu 165 , and His 173 in human cTnI makes the heart more susceptible to cellular acidosis, this condition only occurs in the adult mammalian heart under extreme conditions like ischemia. During embryonic development when cardiac acidosis is common, ssTnI is expressed in the heart (67). Cellular acidosis is however common in fast skeletal muscle following exhaustive anaerobic exercise. There is a distinct benefit to having the protective influence of a His at the equivalent position in fsTnI on myocyte contractility.
Conclusions and Perspectives
The results of this analysis demonstrate that tissue-specific paralogs of TnI and MyBP-C present in fast skeletal, slow skeletal, and cardiac muscle are the result of gene duplication events that occurred after the divergence of tunicates from the vertebrate lineage. Following these duplication events, each tissue-specific paralog began to change in sequence and conferred specialized function and capability to each muscle type. This includes the increased number of phosphorylation sites in both cTnI and cMyBP-C, the loss of PKC targets in fsTnI in an ancestor of all reptiles, birds, and mammals, as well as the replacement of His 163 , Val
165
, and Asn 172 with Ala, Glu, and His, respectively, in mammalian cTnI. These changes in sequence altered the regulatory capacity of these proteins and coincided with the increased complexity of cardiac structure and function. By analyzing how TnI and MyBP-C have changed during vertebrate evolution we have provided new insight into how the functional characteristics of the different muscle types have evolved and have raised new questions into the regulatory control of contractile function.
